Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P C Limburg

Showing results (1-10 of 153) with videos related to

Pageof 16
Sort By:
Mini Reviews in Medicinal Chemistry|August 22, 2006
p38 mitogen-activated protein kinase (MAPK) in rheumatoid arthritisJ Westra, P C Limburg
Annals of the Rheumatic Diseases|November 15, 2005
Autoantibodies to opsonins of apoptotic cells in systemic lupus erythematosusP C Limburg, M Bijl
Clinical Rheumatology|June 1, 1987
Antinuclear antibody (ANA) substrates and quantification techniquesC G Kallenberg, P C Limburg
Nederlands Tijdschrift Voor Geneeskunde|November 30, 1991
[Serological diagnosis in rheumatoid arthritis]M A van Leeuwen, P C Limburg
The Netherlands Journal of Medicine|July 31, 2001
New insights into the pathogenesis of systemic lupus erythematosus (SLE): the role of apoptosisM Bijl, P C Limburg, C G Kallenberg
Lupus|April 1, 1995
Serological markers of disease activity in systemic lupus erythematosusP E Spronk, P C Limburg, C G Kallenberg
Clinical and Experimental Immunology|February 13, 2001
Anti-CD3-induced and anti-Fas-induced apoptosis in systemic lupus erythematosus (SLE)M Bijl, G Horst, P C Limburg, et al.
Clinical and Experimental Rheumatology|January 27, 2004
Membrane proteinase 3 expression on resting neutrophils as a pathogenic factor in PR3-ANCA-associated vasculitisA P van Rossum, P C Limburg, C G Kallenberg
European Journal of Clinical Investigation|June 26, 2001
Effects of smoking on activation markers, Fas expression and apoptosis of peripheral blood lymphocytesM Bijl, G Horst, P C Limburg, et al.
Lupus|January 15, 2002
Fas expression on peripheral blood lymphocytes in systemic lupus erythematosus (SLE): relation to lymphocyte activation and disease activityM Bijl, G Horst, P C Limburg, et al.
Pageof 16

Showing results (1-10 of 153) with videos related to

Sort By:
Pageof 16
Mini Reviews in Medicinal Chemistry|August 22, 2006
p38 mitogen-activated protein kinase (MAPK) in rheumatoid arthritisJ Westra, P C Limburg
Annals of the Rheumatic Diseases|November 15, 2005
Autoantibodies to opsonins of apoptotic cells in systemic lupus erythematosusP C Limburg, M Bijl
Clinical Rheumatology|June 1, 1987
Antinuclear antibody (ANA) substrates and quantification techniquesC G Kallenberg, P C Limburg
Nederlands Tijdschrift Voor Geneeskunde|November 30, 1991
[Serological diagnosis in rheumatoid arthritis]M A van Leeuwen, P C Limburg
The Netherlands Journal of Medicine|July 31, 2001
New insights into the pathogenesis of systemic lupus erythematosus (SLE): the role of apoptosisM Bijl, P C Limburg, C G Kallenberg
Lupus|April 1, 1995
Serological markers of disease activity in systemic lupus erythematosusP E Spronk, P C Limburg, C G Kallenberg
Clinical and Experimental Immunology|February 13, 2001
Anti-CD3-induced and anti-Fas-induced apoptosis in systemic lupus erythematosus (SLE)M Bijl, G Horst, P C Limburg, et al.
Clinical and Experimental Rheumatology|January 27, 2004
Membrane proteinase 3 expression on resting neutrophils as a pathogenic factor in PR3-ANCA-associated vasculitisA P van Rossum, P C Limburg, C G Kallenberg
European Journal of Clinical Investigation|June 26, 2001
Effects of smoking on activation markers, Fas expression and apoptosis of peripheral blood lymphocytesM Bijl, G Horst, P C Limburg, et al.
Lupus|January 15, 2002
Fas expression on peripheral blood lymphocytes in systemic lupus erythematosus (SLE): relation to lymphocyte activation and disease activityM Bijl, G Horst, P C Limburg, et al.
Pageof 16